Popular Articles
Benefits Of Grapefruit

American Cancer Society To Recognize Corporate Employers Changing The Course Of The Cancer Fight
The American Cancer Society - the nation"s leading voluntary health organization and largest non-governmental funder of cancer research and discovery - will present its Corporate Impact Awards June 19 during the Society-hosted Corporate Impact Conference in Chicago. The awards will recognize companies" engagement in targeted efforts to significantly impact cancer"s effect on the workplace, where disease-related expenditures and lost productivity costs annually surpass $228 billion; in contributing funds to the American Cancer Society to fight the disease; and in addressing responsible community involvement.
generic viagra online
Coma, Vegetative State, Minimally Conscious State: Frequent Misdiagnoses And Inconsistent Standards In Europe Pose Ethical Problems
"Latest research raises important ethical issues concerning our care for patients with chronic consciousness disorders," said Professor Gustave Moonen (Liege, Belgium), past president of the European Neurological Society (ENS), at a press conference at the current ENS Congress. This major meeting in European neurology is gathering more than 2,900 experts from all over the world in Milan. "This is all the more important as studies have shown that more than a third of patients given an initial diagnosis of vegetative state or persistent vegetative state show minimal signs of consciousness under more detailed examination."
News of the day
Members Announced For The MHRA's Agency Board
The Medicines and Healthcare products Regulatory Agency (MHRA) and the Appointments Commission are pleased to announce two new appointments and two reappointments of non-executive directors to the Agency Board.
Sexual Health

Common Antibiotics May Be Best First Treatment For Children With MRSA-related Infections

Penicillin and other antibiotics in the beta-lactam family work as well as other antibiotics to treat MRSA (methicillin-resistant Staphylococcuss aureus) infections in the skin and soft-tissue of children and may help prevent further resistance to antibiotic treatment, according to a new study funded by the Agency for Healthcare Research and Quality. The study, published in the June, 2009 issue of Pediatrics, compared treatment outcomes for three different antibiotics beta-lactums (which include penicillin, cephalosporins, carbapenems and monobactams), clindamycin, and trimethoprim-sulfamethoxazole (TMP -SMZ). The study concluded that children treated with clindamycin for skin and soft tissue infections potentially caused by MRSA did not show greater improvement compared to those treated with beta-lactam therapy. Children treated with TMP-SMZ were less likely to show improvement. Among the study"s findings: -- Beta- lactams may still be the best first line initial therapy for skin and soft tissue infections possibly caused by MRSA. -- Community- Acquired MRSA may not be the cause of skin and soft tissue infections even when MRSA is prevalent. -- The use of beta-lactams may help prevent further resistance to antibiotic treatment of skin and tissue infections. -- Beta-lactam therapy is more palatable to children than clindamycin because it is not associated with side effects, such as nausea and mild diarrhea. It is also not as expensive as other treatments. The authors of this study recommend further research to establish a higher level of evidence and to confirm study results. This study was funded by a cooperative agreement through an AHRQ grant to the Centers for Education and Research on Therapeutics (CERTs) research network, which is part of the agency"s Effective Health Care Program. The Effective Health Care Program sponsors the development of new scientific knowledge through studies on the outcomes of health care technologies and services. AHRQ


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):